2[2]Dao Q,K rishmswamy P,kazanegra R,et al.Utility of B-type mtriuretic peptide in the diagnosis of congestive heart failure in an urgentemre setting.J Am Coll Cardiol,2001,37:379-385.
3[3]Anand IS,Fisher LD,Chian4g YT,et al.Changes in B-type natriureticpeptide and norepinephrineovertime and mortality and morbidity in the Valsartan Heart FailureTrial.Circolation,2003,107:1278-1283.
4[4]de Lemos JA,Morrow DA,Bentley JH et al.The prognostic value of B-type natriuretic peptide in patients with acute coronary syn-dromes.N Eng J Med,2001,345(14:)1014.
5[5]7Uustihmaa P,Ruskoaho H,Vuolteemho O,et al.Plasma vasoective poptides after acute myocardial infarction in relation to left ventricular dysfunction.Int J Cardiol,1999,69(1):5-14
9[9]Lang CC,Prasad N,Mcalpine H M,et al.Incresed plasma levels of brain mtriuretie peptidc in patients with isolated diastolic dysfunction.Am Heart J,1994,127(6):1635-1636.
2Lang CC,Prasad N,Mcalpine HM,et al.Increased plasma levels of brain natriuretic peptide in patients with isolated diastolic dysfunction.
3European study group on diastolic heart failure. How to diagnose diastolic heart failure.
4Morrison LK,Harrison A,Krishnaswamy P,et al.Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea.
5Suzuki T,Yamaoki K,Nakajima O,et al.Screening for cardiac dysfunction in asymptomatic patients by measuring B-type natriuretic peptide levels.
6Nagaya N,Nishikimi T,Uematsu M,et al.Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension.
7Morita E, Yasue H, Yoshimura M, et al. Increased plasma level of BNP in patients with AMI [J]. J Am Coil Cardiol, 1993,88: 82 - 91.
8Talwar S, Squire IB, Downie PF, et al. Profile of plasma N-terminal proBNP following acute myocardial infarction; correlation with left ventricular systolic dysfunction [J]. Eur Heart J, 2000,21 ( 18 ):1514 - 1521.
9Richards AM, Nicholls MG, Yandle TG, et al. Plasma NT-proBNP and adrenomedulin. New neurohormonal predictors of left ventricular dysfunction and prognosis after myocardial infarction [ J ]. Circulation, 1998,97:1921 - 1929.
10Sabatine MS. Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide [ J]. Circulation ,2002,105 ( 15 ): 1760 - 1763.
